Request Trial
iaremenko-sergii-shutterstock-com-3d-printing-
Iaremenko Sergii / Shutterstock.com
5 January 2017AmericasArlene Chow and Nitya Anand

New technologies, old framework: maximising IP protection for 3D printing in the life sciences

3D printing technology has transformed the life sciences industry. It is already being used to make marketed medical devices and pharmaceutical products and, with some sources predicting overall 3D printing revenue as high as $21 billion worldwide by 2020, there can be no question that life sciences 3D printing will continue to grow in importance and scope.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026   The Supreme Court's first look at the skinny label dispute dug into key questions, from the role of the skinny label to who Hikma’s statements were really meant for, in one of the most important patent cases in years.
Americas
Blow for Masimo’s fight with Apple as case against US Customs dismissed
29 April 2026   The wearable tech company has had to drop its lawsuit against US Customs and Border Protection, part of the wider, ongoing dispute with Apple over a blood oxygen feature in smart watches.
Americas
Ligand buys biotech in $739m cash deal with litigation sweetener
28 April 2026   Pharma group strikes an all-cash transaction, combining a portfolio expansion with a contingent payment linked to a dispute over a $5 billion drug


Editor's picks

From the courtroom: Hikma v Amarin SCOTUS oral arguments
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026

Editor's picks

Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026
Americas
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
1 April 2026
Europe
WIPR debuts Global In-House Elite 2026
26 March 2026
Biotechnology
mRNA litigation: Who’s winning, who’s filing, and what’s next
25 March 2026

More features

Report: 85% of in-house counsel want IP service providers to embrace AI
From the courtroom: Hikma v Amarin SCOTUS oral arguments
Blow for Masimo’s fight with Apple as case against US Customs dismissed
Ligand buys biotech in $739m cash deal with litigation sweetener
CureVac targets Moderna with 10-patent suit over Spikevax
Safeguarding critical IP in a high-risk era: WIPR Trade Secrets West 2026
EU court under pressure to define SPC limits in patent row
Amneal acquires biopharma ahead of $300bn patent wave